2023 Translational Studies (osteosarcoma)
The Translational Studies Grant from the Osteosarcoma Institute supports researchers worldwide working on osteosarcoma. The proposed study should generate an optimal preclinical dataset for osteosarcoma metastasis drug development. Applicants may apply for up to 500,000 USD, including up to 10% indirect costs. Letters of intent are due on November 15, 2022. Invited full applications are due on April 14, 2023.
Challenge: Rare Diseases
Create or log-in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.